ensartinib

Resumen de Ensayos Clínicos

2 ensayos encontrados
Sobre ensartinib

Se está recopilando información detallada sobre este medicamento.

Categoría Terapia Dirigida
2
Total Ensayos
1
Reclutando
1
Activo
0
Completado
1,541
Inscripción Total
5
Países
Centros activos para ensartinib
Centros reclutando 5 países
Fase:
Study of MCLA-129 in Combination With Ensartinib in Patients With Advanced Solid Tumors.
NCT07448116 Fase 1 Reclutando 164 pacientes
Inicio: Jan 2026
Fin: Aug 2029
Intervencional
Medicamentos: Ensartinib MCLA-129
This is a multicenter, open-label Phase I/II clinical study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of the anti-EGFR/c-Met bispecific antibody MCLA-129 in combination with Ensartinib hydrochloride in patients with advance...
China
Ver Detalles ClinicalTrials.gov ¿Soy elegible?
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
NCT03155620 Fase 2 Activo 1,377 pacientes
Inicio: Jul 2017
Fin: Jan 2027
Intervencional
Medicamentos: Ensartinib Erdafitinib Ivosidenib Olaparib Palbociclib Samotolisib Selpercatinib Tazemetostat Tipifarnib Ulixertinib Vemurafenib
This phase II Pediatric MATCH screening and multi-sub-trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following a...
United States, Australia, Canada, Puerto Rico
Ver Detalles ClinicalTrials.gov ¿Soy elegible?
Volver al Glosario Ver Todos los Ensayos Filtrar Reclutando